Archives: Agenda

Unlocking the power of primary care for site optimisation

Clinical trials are expensive, and choosing ineffective study sites can lead to wasted time and resources. Through collaboration with primary care, sponsors can benefit from targeted identification of the best locations for recruiting their desired patient population and reduce site burden through effective data sharing. Join us to discover how through collaboration with primary care, electronic health records can enhance recruitment from site selection through to screening.

Troubleshooting Challenging Hospital Sites?

  • There are many obstacles to running a successful clinical trial – and hospital sites can be one.
  • Slow to set up, delays to patient recruitment, or poor data quality?
  • TCR-Solutions will share some experience and approaches to troubleshooting these challenges.
  • We cannot treat hospital sites like commercial vendors, and we must find a way to work with hospitals to ensure they deliver on time and target.

PANEL DISCUSSION: Exploring the landscape for oncology clinical trials in the UK

  • New regulations and guidance around running oncology trials in the UK: what do you need to be aware of?
  • Running clinical trials in conjunction with the NHS: how to ensure your trial is a success
  • Developments in UK cancer research: what’s new in 2025?
  • Assessing the impact of political and economic changes on UK oncology trials
  • The role of the cancer drug fund in accelerating oncology clinical trials in the UK

KEYNOTE PRESENTATION: AI in clinical trials: assessing opportunities and challenges in developing an AI strategy

·       How AI and digitalisation can support streamlining of clinical operations and improve efficiency

·       Simple ways to implement tools such as GPT and GenAI in your trial

·       Where can AI be utilized to minimize workloads and increase overall output?

·       The regulatory landscape in the UK for the use of AI in clinical trials: what do you need to know?

·       Key limitations of GenAI and how these impact its potential uses for clinical trials in the UK

KEYNOTE PANEL: Where is the clinical trial industry headed this year and beyond?

• How do we ensure the UK is an attractive location for clinical research
• Navigating new regulations around clinical trials smoothly and successfully
• The impact of artificial intelligence: how far can we expect to move forward in the next 12 months?
• Patient centricity in clinical trials: how can burden be reduced in order to make trials easier for patients to participate in?
• Technological developments in 2025 and beyond: what changes can we expect to see in the next 3-5 years?